Preetam Shah is Chief Financial Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 335,960 shares of CDTX, which is worth approximately $4.5 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 108,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 336K
0% 3M change
41.08% 12M change
Total Value Held $4.5 Million

Preetam Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
-
108,750 Added 24.45%
335,960 Common Stock
Mar 11 2024
SELL
Open market or private sale
$12,683 $0.67 p/Share
18,931 Reduced 7.69%
227,210 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
90,000 Added 27.43%
238,141 Common Stock
Mar 13 2023
SELL
Open market or private sale
$10,171 $1.53 p/Share
6,648 Reduced 4.29%
148,141 Common Stock
Sep 19 2022
SELL
Open market or private sale
$12,044 $0.77 p/Share
15,642 Reduced 9.4%
150,789 Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
-
50,000 Added 23.1%
166,431 Common Stock
Mar 31 2022
SELL
Payment of exercise price or tax liability
$20,601 $0.83 p/Share
24,820 Reduced 18.08%
112,431 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
117,251 Added 46.07%
137,251 Common Stock
Nov 12 2021
BUY
Open market or private purchase
$30,800 $1.54 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

BCLI
BRAINSTORM CELL THERAPEUTICS INC. Healthcare
PS

Preetam Shah

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX